108 related articles for article (PubMed ID: 27621228)
1. Kallikrein-related peptidase 6 promotes psoriasiform skin inflammation through a protease-activated receptor 2-independent mechanism.
Iinuma S; Kishibe M; Saito N; Igawa S; Honma M; Bando Y; Yoshida S; Ishida-Yamamoto A
Exp Dermatol; 2017 Mar; 26(3):289-291. PubMed ID: 27621228
[No Abstract] [Full Text] [Related]
2. Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2.
Kishibe M; Bando Y; Tanaka T; Ishida-Yamamoto A; Iizuka H; Yoshida S
J Invest Dermatol; 2012 Jun; 132(6):1717-24. PubMed ID: 22358061
[TBL] [Abstract][Full Text] [Related]
3. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease.
Billi AC; Ludwig JE; Fritz Y; Rozic R; Swindell WR; Tsoi LC; Gruzska D; Abdollahi-Roodsaz S; Xing X; Diaconu D; Uppala R; Camhi MI; Klenotic PA; Sarkar MK; Husni ME; Scher JU; McDonald C; Kahlenberg JM; Midura RJ; Gudjonsson JE; Ward NL
J Clin Invest; 2020 Jun; 130(6):3151-3157. PubMed ID: 32155135
[TBL] [Abstract][Full Text] [Related]
4. Klk8 is required for microabscess formation in a mouse imiquimod model of psoriasis.
Iinuma S; Kishibe M; Saito N; Igawa S; Honma M; Takahashi H; Bando Y; Yoshida S; Iizuka H; Ishida-Yamamoto A
Exp Dermatol; 2015 Nov; 24(11):887-9. PubMed ID: 26121277
[No Abstract] [Full Text] [Related]
5. Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.
Radulovic M; Yoon H; Wu J; Mustafa K; Fehlings MG; Scarisbrick IA
Neurobiol Dis; 2015 Nov; 83():75-89. PubMed ID: 26316358
[TBL] [Abstract][Full Text] [Related]
6. Trem-1 is not crucial in psoriasiform imiquimod-induced skin inflammation in mice.
Joffre J; Hau E; Zeboudj L; Laurans L; Battistella M; Boufenzer A; Masson A; Le Buanec H; Cochaud S; Bagot M; Bensussan A; Gibot S; Bouaziz JD; Ait-Oufella H
Exp Dermatol; 2016 May; 25(5):400-2. PubMed ID: 26782119
[No Abstract] [Full Text] [Related]
7. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
Kishibe M
J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
[TBL] [Abstract][Full Text] [Related]
8. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
9. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
10. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris.
Iwakiri K; Ghazizadeh M; Jin E; Fujiwara M; Takemura T; Takezaki S; Kawana S; Yasuoka S; Kawanami O
J Invest Dermatol; 2004 Apr; 122(4):937-44. PubMed ID: 15102084
[TBL] [Abstract][Full Text] [Related]
11. Increase in pruritogenic kallikrein 5 in the skin of NC mice with chronic dermatitis.
Andoh T; Tsujii K; Kuraishi Y
Exp Dermatol; 2015 Dec; 24(12):978-80. PubMed ID: 26268952
[No Abstract] [Full Text] [Related]
12. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model.
Briot A; Lacroix M; Robin A; Steinhoff M; Deraison C; Hovnanian A
J Invest Dermatol; 2010 Dec; 130(12):2736-42. PubMed ID: 20703245
[TBL] [Abstract][Full Text] [Related]
13. Epidermal expression of 65 and 72 kd heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis.
Puig L; Fernández-Figueras MT; Ferrándiz C; Ribera M; de Moragas JM
J Am Acad Dermatol; 1995 Dec; 33(6):985-9. PubMed ID: 7490370
[TBL] [Abstract][Full Text] [Related]
14. NGF-p75 and neuropsin/KLK8 pathways stimulate each other to cause hyperkeratosis and acanthosis in inflamed skin.
Shingaki K; Taniguchi M; Kanazawa S; Matsuzaki S; Maeda T; Miyata S; Kubo T; Torii K; Shiosaka S; Tohyama M
J Dermatol Sci; 2012 Jul; 67(1):71-3. PubMed ID: 22520925
[No Abstract] [Full Text] [Related]
15. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
16. Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model.
Nakajima K; Terao M; Takaishi M; Kataoka S; Goto-Inoue N; Setou M; Horie K; Sakamoto F; Ito M; Azukizawa H; Kitaba S; Murota H; Itami S; Katayama I; Takeda J; Sano S
J Invest Dermatol; 2013 Nov; 133(11):2555-2565. PubMed ID: 23633022
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosis.
Soler DC; Young AE; Griffith AD; Fu PF; Cooper KD; McCormick TS; Popkin DL
Exp Dermatol; 2017 Oct; 26(10):949-951. PubMed ID: 28111811
[TBL] [Abstract][Full Text] [Related]
19. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling.
Zhang B; Xie S; Su Z; Song S; Xu H; Chen G; Cao W; Yin S; Gao Q; Wang H
Sci Rep; 2016 Feb; 6():21132. PubMed ID: 26893174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
